Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective by González-Cueto, E, de la Fuente, J, López-Camacho, C

Production and purification of Zika virus NS1 glycoprotein in HEK293 cells by Kim, YC, Garcia-Larragoiti, N, Lopez-Camacho, C, Viveros-Sandoval, ME, Reyes-Sandoval, A

A single and un-adjuvanted dose of a chimpanzee adenovirus-vectored vaccine against chikungunya virus fully protects mice from lethal disease by Campos, R, Preciado-Llanes, L, Azar, SR, Lopez-Camacho, C, Reyes-Sandoval, A, Rossi, SL

In vitro platelet activation response induced by Dengue non structural protein 1 by García-Larragoiti, N, Kim, Y, López-Camacho, C, Vázquez-Garcidueñas, S, Reyes-Sandoval, A, Viveros-Sandoval, ME

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers by López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A

Evaluation of chimpanzee adenovirus and MVA expressing TRAP and CSP from Plasmodium cynomolgi to prevent malaria relapse in nonhuman primates by Kim, YC, Dema, B, Rodriguez-Garcia, R, López-Camacho, C, Leoratti, FMS, Lall, A, Remarque, EJ, Kocken, CHM, Reyes-Sandoval, A

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus by López-Camacho, C, Chan Kim, Y, Blight, J, Lazaro Moreli, M, Montoya-Diaz, E, T Huiskonen, J, Mareike Kümmerer, B, Reyes-Sandoval, A

Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors by de la Fuente, J, Ghosh, S, Lempereur, L, Garrison, A, Sprong, H, Lopez-Camacho, C, Maritz-Olivier, C, Contreras, M, Moraga-Fernández, A, Bente, DA

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine by Alves, E, Salman, A, Leoratti, F, Lopez-Camacho, C, Viveros-Sandoval, M, Lall, A, El-Turabi, A, Bachmann, M, Hill, A, Khan, S, Reyes-Sandoval, A

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection by Mann, GS, Francisco, AF, Jayawardhana, S, Taylor, MC, Lewis, MD, Olmo, F, Oliveira de Freitas, E, Leoratti, FMS, López-Camacho, C, Reyes-Sandoval, A, Kelly, JM

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection by Campos, JL, Dejnirattisai, W, Jagger, BW, Lopez-Camacho, C, Wongwiwat, W, Durnell, LA, Winkler, ES, Chen, RE, Reyes-Sandoval, A, Rey, FA, Diamond, MS, Mongkolsapaya, J, Screaton, G

Development of an E2 ELISA methodology to assess chikungunya seroprevalence in patients from an endemic region of Mexico by Kim, Y, López-Camacho, C, Garcia-Larragoiti, N, Cano-Mendez, A, Hernandez-Flores, K, Domínguez-Alemán, C, Mar, M, Vivanco-Cid, H, Viveros-Sandoval, M, Reyes-Sandoval, A

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. by Tatsis, N, Fitzgerald, J, Reyes-Sandoval, A, Harris-McCoy, K, Hensley, SE, Zhou, D, Lin, S, Bian, A, Xiang, Z, Iparraguirre, A, Lopez-Camacho, C, Wherry, E, Ertl, H

A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins by Hancock, G, Blight, J, Lopez-Camacho, C, Pocock, M, Byrne, W, Price, M, Kemlo, P, Evans, R, Saunders, K, Kirton, R, Andersson, M, Hellner, K, Reyes-Sandoval, A, Dorrell, L

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model by Matos, ADS, Soares, IF, Rodrigues-da-Silva, RN, Rodolphi, CM, Albrecht, L, Donassolo, RA, Lopez-Camacho, C, Ano Bom, APD, Neves, PCDC, Conte, FDP, Pratt-Riccio, LR, Daniel-Ribeiro, CT, Totino, PRR, Lima-Junior, JDC

Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants. by Rodrigues-da-Silva, R, Soares, I, Lopez-Camacho, C, da Silva, J, Perce-da-Silva, D, Têva, A, Franco, A, Pinheiro, F, Chaves, L, Pratt-Riccio, L, Reyes-Sandoval, A, Banic, D, Lima-Junior, J

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models by Salman, A, Montoya-Díaz, E, West, H, Lall, A, Atcheson, E, Lopez-Camacho, C, Ramesar, J, Bauza, K, Collins, K, Brod, F, Reis, F, Pappas, L, González-Cerón, L, Janse, C, Hill, A, Khan, S, Reyes-Sandoval, A

Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region by Kim, Y, Lopez-Camacho, C, Nettleship, J, Rahman, N, Hill, M, Silva-Reyes, L, Ortiz-Martinez, G, Figueroa-Aguilar, G, Mar, M, Vivanco-Cid, H, Rollier, C, Zitzmann, N, Viveros-Sandoval, M, Owens, R, Reyes-Sandoval, A

Antibody responses against Plasmodium vivax trap recombinant and synthetic antigens in naturally exposed individuals from the Brazilian Amazon by Matos, A, Rodrigues-Da-Silva, R, Soares, I, Baptista, B, De Souza, R, Bitencourt-Chaves, L, Rivas Totino, P, Sanchez-Arcila, J, Daniel-Ribeiro, C, Lopez-Camacho, C, Reyes-Sandoval, A, Pratt-Riccio, L, Lima-Junior, J

Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial by Folegatti, PM, Harrison, K, Lopez, KR, Tilley, MW, Lopez-Camacho, C, Kim, YC, Preciado-Llanes, L, Rossi, SL, Poulton, I, Jenkin, D, Datoo, M, Themistocleous, Y, Lawrie, A, Roberts, R, Ewer, K, Berrie, E, Hill, A, Reyes-Sandoval, A